Curcio, C.; Brugiapaglia, S.; Bulfamante, S.; Follia, L.; Cappello, P.; Novelli, F.
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules 2021, 26, 1642.
https://doi.org/10.3390/molecules26061642
AMA Style
Curcio C, Brugiapaglia S, Bulfamante S, Follia L, Cappello P, Novelli F.
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules. 2021; 26(6):1642.
https://doi.org/10.3390/molecules26061642
Chicago/Turabian Style
Curcio, Claudia, Silvia Brugiapaglia, Sara Bulfamante, Laura Follia, Paola Cappello, and Francesco Novelli.
2021. "The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer" Molecules 26, no. 6: 1642.
https://doi.org/10.3390/molecules26061642
APA Style
Curcio, C., Brugiapaglia, S., Bulfamante, S., Follia, L., Cappello, P., & Novelli, F.
(2021). The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules, 26(6), 1642.
https://doi.org/10.3390/molecules26061642